ALICIA HORTON: Open Payments
NPI 1700650140 · NEW PROVIDNCE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,481 in 78 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $853 · 2025 $1,481
Food & beverage: $1,481
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $406 |
| ABBVIE INC. | 14 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $263 |
| AstraZeneca Pharmaceuticals LP | 9 | $182 |
| Lilly USA, LLC | 5 | $104 |
| PFIZER INC. | 6 | $97 |
| Exact Sciences Corporation | 2 | $40 |
| Amgen Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: CAPLYTA, Wegovy, AIRSUPRA, QULIPTA, UBRELVY, Ozempic, MOUNJARO, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
